Prostate cancer therapies can negatively impact patients’ sexual function; this can lead to changes in their relationship with their partner. Reliable information or support is not always available, contributing to distress and relationship breakdowns. These Guidelines provide information about the comprehensive support that patients and partners need. It ultimately exists to support clinicians in helping men and their partners live healthier lives, after prostate cancer treatment.
These Guidelines include 47 statements and recommendations that aim to:
Provide a biopsychosocial perspective on patients’ and partners’ recovery of sexual intimacy after prostate cancer treatment. It includes recognition of cultural, ethnic, racial, sexual and gender diversity as well as differences in healthcare and legal systems in which care must be considered.
Summarize the existing evidence for biopsychosocial rehabilitation.
Increase clinician preparedness and confidence to initiate sensitive conversations about sexual concerns with patients and partners, and foster meaningful, ongoing support.
Enable clinicians to empower patients with prostate cancer to take ownership of their sexual recovery.
Drive better consistency of care and best practices amongst the global clinical community.
Document gaps in care that still need further research and implementation strategies.
Download Patient Guidelines
The development of these guidelines marks the first time that research and clinical expertise on sexual health care in prostate cancer have been comprehensively summarized to influence and guide clinical practice.
To learn more about the development process, go here.
The team of international experts included physicians (urologic, medical and radiation oncologists, sexual medicine urologists, a primary care physician), mental health clinicians with sexual health expertise (psychologists and social workers), nurses, and physical therapists. Men with lived experience and partners were also invited to add their perspectives to the guideline development. Considerations were made for representation from as many countries and cultures as possible.Guidelines Chair
Daniela Wittmann, PhD, LMSW. Associate Professor Emerita of Urology, Adjunct Clinical Associate Professor of Social Work, Department of Urology and School of Social Work, University of Michigan, Ann Arbor, Michigan, USA.
The late Eilis McCaughan, PhD. Professor in Cancer Care, Ulster University School of Nursing, Coleraine, Northern Ireland, United Kingdom.
In total, the Guidelines had input from 37 co-authors, 26 peer reviewers and 2 patient advocates, spanning 14 countries globally.
Full list of contributors can be found within these Guidelines.
Eilis McCaughan was a caring nurse, dedicated researcher, beloved mother, and dear friend to all who knew her. She made a significant contribution to the mission of Movember by leading the UK team of researchers in the development of three resources for sexual health care after prostate cancer therapies: a support tool for men with lived experience and their partners, a brief tool to help clinicians engage patients in a conversation about the sexual side-effects of prostate cancer treatment, and an educational program about sexual health in prostate cancer for clinicians. Her efforts and leadership extended significantly to the guideline effort. The legacy of her work carries forward and on through those she worked with and influenced, as well as the community of patients and partners she so passionately served.
Movember is the leading charity changing the face of men’s health on a global scale, focusing on prostate cancer, testicular cancer and mental health and suicide prevention. We raise funds to deliver innovative, breakthrough research and support programs that enable men to live healthier and longer lives.
Movember proudly funds True North, a global prostate cancer initiative.